Miami Beach, Florida
Exosome supply and 503A pharmacy access for Miami Beach practices
ExaVeyra Sciences is based in Miami Beach, and a practice on the island sources from a supplier a few minutes away rather than a flight. Florida is a state where the 503A pharmacy partner holds a non-resident license, so research-use exosome material is supplied to a licensed Miami Beach practice on its verified account, a prescriber here can send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly, and the Miami page on this site covers the county-wide logistics in detail.
This page covers what is specific to the island: where practices sit, how a local delivery differs from a shipped one, and which questions the Florida guide answers instead.
What a Miami Beach practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Florida, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Miami Beach
Miami Beach holds one of the densest aesthetic-practice populations in Florida on a very small footprint. The clinical anchor is Mount Sinai Medical Center on the Mid-Beach bayfront, and the private practices cluster in three areas: the 41st Street and Alton Road corridor in Mid-Beach, where dermatology, plastic surgery and concierge groups occupy the medical office buildings around the hospital; South of Fifth and the Lincoln Road district in South Beach, where medical aesthetics and wellness practices take ground-floor and boutique space; and the North Beach and Normandy Isles stretch, which connects to Surfside, Bal Harbour and Bay Harbor Islands, each with its own concierge and cosmetic practice base.
The island's population is both seasonal and international, with a winter peak from the art fair calendar through spring and a steady flow of visitors who consult practices here while in the city, and that shapes how practices plan: frozen exosome formats are held across the season, while a compounded preparation is dispensed by the pharmacy against the patient's prescription when it is written. The causeways to the mainland, the Julia Tuttle, the MacArthur, the Venetian and the 79th Street, are the routes on and off the island, which matters for delivery timing during the events that close them.
Parking and building access are the details that decide a delivery on the island. Many practice suites in Mid-Beach and South Beach sit in buildings with valet-only garages or metered street parking, and a courier who cannot stop at the door will hand the package to a lobby desk. The account therefore records the entrance the practice wants used and the staff member who signs, and for a local handover the ExaVeyra team confirms the time window on the day so that the material moves from the vehicle to the practice freezer without an interval on a counter.
The hair and scalp literature, for Miami Beach practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
The hair and scalp series on this site is the evidence reference for each formulation class the literature discusses, and for a Miami Beach practice the sourcing position is that research-use exosome formats are supplied on the practice's verified account, and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes. The evidence pages set out the literature and the FDA communications for each component, and the product category lists what the pharmacy partner prepares to prescription.
What does not change with proximity is the regime each product class sits in: exosome material remains research-use material with a certificate of analysis available for the lot, and a compounded preparation remains a prescription product prepared for one patient. The Florida guide answers who may prescribe a compounded preparation and how Florida delegation rules read, and a supplier answers neither.
How material reaches Miami Beach
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Florida practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Florida destinations sit on the shortest lane ExaVeyra runs, and cold-chain shipping is free to Florida destinations from 6 units against 15 units nationwide; the threshold is applied by the cart rather than quoted case by case.
Florida law is a separate question, answered in the state guide
What a Florida practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Florida sourcing guide rather than repeated here. Nothing about the city changes any of it.
Miami Beach sourcing questions
- Can a Miami Beach practice collect material rather than have it shipped?
- Local delivery and collection arrangements are made with the ExaVeyra team when the account is set up, and the practice named on the account, or a staff member it designates in writing, receives the material and signs the chain-of-custody record. The temperature log and the receiving checks are the same for a local handover as for a shipped package: read the indicator, log the arrival time, and move the material to its storage temperature at once.
- What does the Miami page cover that this one does not?
- The Miami page covers the logistics that apply county-wide: the fulfilment window on Florida destinations, the free cold-chain threshold and how the cart applies it, and the documentation a South Florida practice should hold. This page covers the island itself. A practice in Surfside, Bal Harbour or Bay Harbor Islands is served the same way as one in Mid-Beach.
- Does the Florida compounding availability apply to a prescriber who visits the island seasonally?
- A compounded preparation is dispensed by the pharmacy partner against an individual prescription, and whether a prescription is valid for a patient in another state, and which licence the prescriber needs to write it, are questions for the pharmacy partner and the two states' boards rather than for a supplier. A prescriber who holds a Florida license and practises here for part of the year should read the Florida guide, which links the Florida Board of Medicine and the Board of Pharmacy.
Sources
- City of Miami Beach, official site (accessed 15 September 2026)
- Florida Department of Health, license verification (accessed 15 September 2026)
- Florida Board of Medicine (accessed 15 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.